Unknown OBSERVATIONAL NCT01422057

Risk Prediction in Type II Diabetics With Ischemic Heart Disease

Risk Prediction in Type II Diabetics With Ischemic Heart Disease by Cardiac Autonomic Function

Sponsor: Thebiosignals.com

Conditions Ischemic Heart Disease Type-2 Diabetes Mellitus

Updated 6 times since 2017 Last updated: Feb 5, 2014 Started: Jan 31, 2010 Primary completion: Jan 31, 2014 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Ischemic Heart Disease and Type-2 Diabetes Mellitus and is currently ongoing. Thebiosignals.com leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Thebiosignals.com

Data source: Thebiosignals.com

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tübingen, Germany